eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
5/2019
vol. 36
 
Share:
Share:
more
 
 
abstract:
Original paper

The use of nasal over-the-counter agents in the evaluated Polish population. The underrated role of the pharmacist in patient education on medical treatment in patients with allergic rhinitis

Oksana Wojas
,
Edyta Krzych-Fałta
,
Konrad Furmańczyk
,
Adam Sybilski
,
Mira Lisiecka-Biełanowicz
,
Bolesław Samoliński

Adv Dermatol Allergol 2019; XXXVI (5): 524-530
Online publish date: 2019/11/12
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The goal of treatment in allergic rhinitis is a complete elimination of symptoms or achieving significant clinical improvement. The role of the pharmacist has been receiving particular attention in terms of the initial diagnosis and treatment of allergic rhinitis patients and their sufficiently early referral to a specialist in case of persistent symptoms.

Aim
This study attempted to estimate the rates of nasal OTC use in patients diagnosed with allergic rhinitis.

Material and methods
Study population was 18,578 subjects (4,192 patients diagnosed with AR and 14,386 healthy controls): children aged 6–7 years, adolescents aged 13–14 years, and adults aged 20–44 years. We used translated and validated versions of ECRHS and ISAAC questionnaires.

Results
The rates of nasal decongestant use in the allergic rhinitis group were 60.4% in children, 50.7% in adolescents, and 43.0% in adults, with these figures significantly higher than in the control group (p < 0.05).The most common nasal agent was Oxymetazoline and Xylometazolini hydrochloridum 0.1%.

Conclusions
Over a half of the evaluated allergic rhinitis patients used nasal decongestants, which poses a potential risk of uncontrolled side effects. There is an urgent need to introduce patient education on medical treatment.

keywords:

allergic rhinitis, over-the-counter (OTC) nasal decongestants, patient education on medical treatment or pharmacist education

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe